Steel and mining company ArcelorMittal (OTCPK:AMSYF) announced on Friday the sale of its operations in Bosnia and Herzegovina ...

Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year. The trial results are among the ...

The headline numbers for Lilly (LLY) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes. Skip to content Main Navigation ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes. Skip to content Main Navigation ...

Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer By Annika Kim Constantino, CNBC • Published March 24, 2025 • Updated on March 24, 2025 at 1: ...

Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year.The company has said it expects to unveil ...

Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer By Annika Kim Constantino, CNBC • Published March 24, 2025 • Updated on March 24, 2025 at 1: ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes. Skip to content Main Navigation ...

Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year.The company has said it expects to unveil ...

Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year.The company has said it expects to unveil ...

Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year.The company has said it expects to unveil ...